We announced today that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted authorization for our respiratory syncytial virus (RSV) vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by… https://t.co/XdcsrMc6ea